high dose methotrexate

DRUG3 trials

Sponsors

International Extranodal Lymphoma Study Group (IELSG), The Hospital for Sick Children, The Korean Society of Pediatric Hematology Oncology

Conditions

Acute Lymphoblastic LeukemiaChildLymphoma, B CellOsteosarcoma

Phase 2

Phase II Trial of Combined Modality Treatment in Primary Central Nervous System Lymphoma

CompletedNCT00210314

International Extranodal Lymphoma Study Group (IELSG)Lymphoma, B Cell

Start: 2003-07-31End: 2007-12-31Updated: 2015-03-30

Treatment of Newly Diagnosed High Risk Acute Lymphoblastic Leukemia in Children

The Korean Society of Pediatric Hematology OncologyAcute Lymphoblastic Leukemia, Child

Start: 2015-01-31End: 2023-04-30Target: 110Updated: 2015-01-16

Phase 3

Outpatient Administration of High Dose Methotrexate (HD MTX) in Patients With Osteosarcoma

CompletedNCT01176981

The Hospital for Sick ChildrenOsteosarcoma

Start: 2010-10-31End: 2012-10-31Updated: 2021-10-28

Related Papers

High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial.

2009-09-18441 citations